SARAH GARZA: Open Payments
NPI 1972513471 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 53 payments from 12 companies in 2025. Trend: 2023 $583 · 2024 $798 · 2025 $1,137
Food & beverage: $1,053Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $406 |
| Janssen Biotech, Inc. | 17 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| GENZYME CORPORATION | 2 | $61 |
| Ardelyx, Inc. | 2 | $60 |
| Madrigal Pharmaceuticals | 2 | $52 |
| PFIZER INC. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: TREMFYA, RINVOQ, DUPIXENT, CREON, ENTYVIO, IBSRELA, REZDIFFRA, SKYRIZI.
Industry payments across CO — which companies pay providers there.
